WHO
REGULATORY UPDATE
Active Pharmaceutical Ingredient (API) Prequalified
Published: 10/13/2026Detected: 9/5/2026
Summary preview
WHO prequalifies the pyrazinamide API from Resonance Specialities Limited for use by manufacturers of finished pharmaceutical products (FPPs) in tuberculosis therapy.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
manufacturing
quality
#WHO prequalification
#active pharmaceutical ingredient
#APIMF
#WHO GMP
#tuberculosis
Official Source Document Source Verified
Access the original document directly from WHO.